Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 169.60B | 152.41B | 125.93B | 110.05B | 95.31B |
Gross Profit | 98.76B | 84.66B | 73.82B | 63.01B | 52.74B |
EBITDA | 70.41B | 63.56B | 54.25B | 46.30B | 37.39B |
Net Income | 48.45B | 43.37B | 36.74B | 32.55B | 24.92B |
Balance Sheet | |||||
Total Assets | 312.98B | 243.48B | 217.37B | 187.37B | 163.71B |
Cash, Cash Equivalents and Short-Term Investments | 166.78B | 125.19B | 102.12B | 107.26B | 71.24B |
Total Debt | 11.92B | 12.16B | 11.75B | 6.10B | 6.83B |
Total Liabilities | 86.68B | 48.40B | 56.24B | 40.89B | 42.92B |
Stockholders Equity | 226.30B | 195.08B | 161.13B | 146.47B | 120.80B |
Cash Flow | |||||
Free Cash Flow | 61.34B | 31.79B | 14.37B | 42.88B | 11.50B |
Operating Cash Flow | 67.62B | 36.92B | 21.79B | 46.95B | 14.63B |
Investing Cash Flow | -7.27B | -5.96B | -7.68B | -7.43B | -4.23B |
Financing Cash Flow | -18.73B | -15.97B | -22.48B | -9.98B | -6.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $80.12B | 17.53 | 24.36% | 2.12% | 2.86% | 19.96% | |
76 Outperform | $43.70B | 43.85 | 15.46% | 0.45% | 2.68% | -6.15% | |
75 Outperform | $11.91B | 32.18 | 26.13% | 0.85% | 33.40% | 107.99% | |
72 Outperform | $81.35B | ― | -401.21% | ― | 27.39% | 16.59% | |
60 Neutral | $43.46B | 1.72 | -10.46% | 4.00% | 2.36% | -37.95% | |
59 Neutral | $1.36B | 15.75 | -220.61% | 10.81% | 4.98% | -60.29% | |
55 Neutral | $42.83B | ― | -89.29% | ― | 7.33% | -7.46% |